Expanded clinical network Centricity Research has grown into one of North America’s largest clinical research networks with over 40 wholly owned and integrated offices across North America, signaling capacity to scale trials and quickly deploy sites for multi-region studies.

Recent strategic acquisitions The acquisition of Lucas Research in December 2023 indicates a rapid expansion strategy and potential for cross-sell of services, increased therapeutic coverage, and accelerated access to new geographies for sponsors.

Leadership and governance New CEO and CFO appointments in 2023 suggest a period of strategic realignment and potential emphasis on disciplined financial management, operational efficiency, and enhanced investor confidence for growth initiatives.

Therapeutic breadth With capabilities spanning Phase I–IV across more than 35 therapeutic areas, Centricity offers versatile trial operations appealing to sponsors seeking a single partner for diverse programs and fasterOverall cycle times.

Growth via partnerships Joint growth with Trinity Hunt, focusing on organic and acquisitive expansion, signals opportunities to position Centricity as a preferred collaborator for sponsors seeking scale, regional coverage, and integrated site networks.